2020
Primary Treatment Selection for Clinically Node-Negative Merkel Cell Carcinoma of the Head and Neck
Jacobs D, Olino K, Park HS, Clune J, Cheraghlou S, Girardi M, Burtness B, Kluger H, Judson BL. Primary Treatment Selection for Clinically Node-Negative Merkel Cell Carcinoma of the Head and Neck. Otolaryngology 2020, 164: 1214-1221. PMID: 33079010, DOI: 10.1177/0194599820967001.Peer-Reviewed Original ResearchConceptsNode-negative Merkel cell carcinomaLymph node evaluationImproved overall survivalPrimary tumor excisionMerkel cell carcinomaCase volumeOverall survivalSurgical managementCell carcinomaTumor excisionTreatment selectionNode evaluationCox proportional hazards regressionGuideline-recommended carePrimary treatment selectionNational Cancer DatabaseNode-negative diseasePercentage of patientsRetrospective cohort analysisInitial surgical managementKaplan-Meier analysisWide local excisionProportional hazards regressionRates of receiptInitial managementUse of prophylactic cranial irradiation in patients with extensive-stage small cell lung cancer receiving immunotherapy.
Yang D, Jairam V, Park H, Decker R, Chiang A, Gross C, Yu J. Use of prophylactic cranial irradiation in patients with extensive-stage small cell lung cancer receiving immunotherapy. Journal Of Clinical Oncology 2020, 38: e19309-e19309. DOI: 10.1200/jco.2020.38.15_suppl.e19309.Peer-Reviewed Original ResearchExtensive-stage small-cell lung cancerFirst-line chemoSmall cell lung cancerES-SCLC patientsCell lung cancerSurvival benefitIO patientsLung cancerStudy periodFirst-line atezolizumabInitial systemic therapyProphylactic cranial irradiationFirst-line chemotherapyRetrospective cohort analysisContemporary practice patternsDe-identified databaseUse of PCIEffectiveness of PCICHEMO patientsCranial irradiationIO therapyPCI useSystemic therapyMRI surveillancePractice patterns
2009
Outcomes From 3144 Adrenalectomies in the United States: Which Matters More, Surgeon Volume or Specialty?
Park HS, Roman SA, Sosa JA. Outcomes From 3144 Adrenalectomies in the United States: Which Matters More, Surgeon Volume or Specialty? JAMA Surgery 2009, 144: 1060-1067. PMID: 19917944, DOI: 10.1001/archsurg.2009.191.Peer-Reviewed Original ResearchMeSH KeywordsAdrenal Gland NeoplasmsAdrenalectomyAdultAgedClinical CompetenceCohort StudiesFemaleFollow-Up StudiesHospital CostsHospital MortalityHumansLogistic ModelsMaleMiddle AgedMultivariate AnalysisOutcome Assessment, Health CarePractice Patterns, Physicians'ProbabilityRegistriesRetrospective StudiesRisk FactorsSpecializationSurvival RateTreatment OutcomeUnited StatesWorkloadConceptsHigh-volume surgeonsSurgeon volumeHospital volumeMore complicationsGeneral surgeonsUtilization Project Nationwide Inpatient SampleRetrospective cohort analysisNationwide Inpatient SampleLow-volume surgeonsPredictors of costsInpatient hospital costsTotal inpatient hospital costsHospital complicationsHospital lengthAdrenal volumeClinical characteristicsHospital factorsAdrenal diseaseIndependent predictorsLonger LOSPatient ageSurgeon specialtyInpatient SampleHospital costsLaparoscopic expertise